Tag Archive for: HCP engagement

This strategic acquisition combines BioCentric’s medical affairs and commercial expertise with JPA Health’s integrated services, predictive analytics and AI-driven solutions.

EVERSANA INTOUCH has announced a new leader for the medical communications function of the agency. Industry veteran Mary Manna Anderson has joined as the senior VP, managing director, head of medcomm and will oversee both global and U.S. medical communications services as well as future service expansion.

This acquisition has more than doubled Real Chemistry’s present medical team, empowering both new and current clients to have access to unparalleled expertise in HCP engagement and communications.

EVERSANA ORCHESTRATE™ transcends the limitations of traditional omnichannel solutions by activating EVERSANA’s full commercialization services, including global agency network solutions, patient support services and field deployment teams, including promotional, medical, and market access solutions.

Customer engagement is instrumental in providing insights on products or services to pharmaceutical decision-makers so they can cater to diverse patient needs. It can also help raise and address current challenges, aiding the move towards patient-centric approaches and improving customer satisfaction.

Without question, there has been significant progress in pinpointing treatments and accelerating rare disease diagnosis, largely due to the precision of data-driven commercial strategies and the speed of digital clinical trials.

Justin Chase, executive vice president of media, EVERSANA INTOUCH discusses trends in social media how healthcare communicators can leverage different platforms to build stronger relationships with patients and HCPs.

The advertising technology company will be integrated into Swoop, creating a unified HCP and DTC system of engagement for healthcare marketers. The growth also expands Real Chemistry’s capabilities and technology offerings.

Medical science liaisons (MSLs) play an essential and prominent role in the pharmaceutical industry. To support the various market changes, the scope of the average MSL function will expand. This article explores the evolving role of MSLs and their value for biopharmaceutical companies, and examines how best to utilize their expertise.